Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-031630
Filing Date
2017-05-11
Accepted
2017-05-11 18:45:17
Documents
1
Period of Report
2017-05-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4003
  Complete submission text file 0001209191-17-031630.txt   5321
Mailing Address 18 DESBROSSES STREET NEW YORK NY 10013
Business Address
AKKARAJU SRINIVAS (Reporting) CIK: 0001253170 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37378 | Film No.: 17835801

Mailing Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121 858-731-8389
aTYR PHARMA INC (Issuer) CIK: 0001339970 (see all company filings)

EIN.: 203435077 | State of Incorp.: DE
SIC: 2836 Biological Products, (No Diagnostic Substances)